Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction
- Conditions
- Breast Cancer
- Interventions
- Procedure: LTP flap
- Registration Number
- NCT03106233
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
The lateral thigh perforator (LTP) flap was previously introduced as an alternative flap for autologous breast reconstruction when the abdomen is not suitable as a donor site. In this prospective study all LTP flap breast reconstructions that have been performed since September 2012 are analyzed. In addition, the surgical refinements that were introduced over the years are reported.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 86
- Lateral thigh region suitable as a donor site
- Abdomen not suitable as donor site
- Informed consent
- Pre-operative imaging showing no suitable perforators
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description LTP flap breast reconstruction LTP flap All consecutive patients who underwent LTP flap breast reconstructions (unilateral, bilateral or stacked unilateral) between September 2012 and November 2016 at three centers in Maastricht, the Netherlands, and New York and New Orleans, the United States, were included. Autologous breast reconstruction was performed by using the upper lateral thigh region as a donor site.
- Primary Outcome Measures
Name Time Method Recipient- and donor-site complications Through study completion up to an average of 12 months post-operatively Recipient site: Total flap loss, partial flap loss, venous congestion, infection, hematoma, seroma, fat necrosis and wound complications. Donor site: Infection, hematoma, seroma, fat necrosis, wound complications.
- Secondary Outcome Measures
Name Time Method Flap re-explorations Through study completion up to an average of 12 months post-operatively Total number of flaps that required a re-exploration because of arterial or venous insufficiency, hematoma or kinking of the pedicle.
Trial Locations
- Locations (1)
Maastricht University Medical Center
🇳🇱Maastricht, Limburg, Netherlands